Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer

Toru Sugiyama, Takashi Nishida, Koichiro Komai, H Nishimura, M Yakushiji, H Nishimura

International Journal of Gynecology & Obstetrics · 1996 · 37 citations · 16 references

Abstract

A screening threshold (cut-off level) of 16 U/ml for CA 125 should be used to detect recurrent serous ovarian adenocarcinoma. Although ultrasound is a convenient method of detecting intrapelvic lesions, and has cost benefit, CT is necessary to detect extrapelvic recurrence. Neither CT nor ultrasound are more accurate than serial CA 125 assays in detecting disease recurrence.

References

16